Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,219 | 84,585 | 76,201 | 71,981 | 94,143 |
| Marketable Securities | 31,746 | 11,354 | 4,873 | 18,975 | 8,096 |
| Receivables | 32,011 | 47,837 | 40,350 | 32,526 | 25,543 |
| Inventories | 8,724 | 7,080 | 4,526 | 7,109 | 3,454 |
| Other current assets | 91 | 912 | 2,429 | 447 | 3,641 |
| TOTAL | $147,658 | $156,185 | $134,281 | $140,022 | $146,139 |
| Non-Current Assets | |||||
| PPE Net | 515 | 855 | 1,146 | 1,756 | 2,481 |
| Intangibles | 51,131 | 60,871 | 70,610 | 66,125 | 74,140 |
| Other Non-Current Assets | 14,029 | 12,617 | 16,022 | 18,682 | 21,460 |
| TOTAL | $65,675 | $74,343 | $87,778 | $86,563 | $98,081 |
| Total Assets | $213,333 | $230,528 | $222,059 | $226,585 | $244,220 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 45,329 | 33,997 | N/A | N/A | 14,286 |
| Accounts payable and accrued liabilities | 5,509 | 6,889 | 6,440 | 11,174 | 12,076 |
| Accrued Expenses | 36,898 | 52,721 | 65,534 | 92,575 | 82,318 |
| Other current liabilities | 2,835 | 975 | 1,370 | 2,263 | 2,481 |
| TOTAL | $96,111 | $99,382 | $77,484 | $109,586 | $114,255 |
| Non-Current Liabilities | |||||
| Long Term Debt | 21,719 | 65,659 | 98,307 | 97,092 | 84,025 |
| Other Non-Current Liabilities | 3,378 | 12,045 | 24,660 | 22,353 | 51,891 |
| TOTAL | $25,097 | $77,704 | $122,967 | $119,445 | $135,916 |
| Total Liabilities | $121,208 | $177,086 | $200,451 | $229,031 | $250,171 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,611 | 48,207 | 46,641 | 41,333 | 40,258 |
| Common Shares | 5 | 5 | 5 | 4 | 4 |
| Retained earnings | -1,314,886 | -1,345,164 | -1,366,755 | -1,366,757 | -1,337,631 |
| Other shareholders' equity | 6 | -4 | 0 | -2 | 0 |
| TOTAL | $92,125 | $53,442 | $21,608 | $-2,446 | $-5,951 |
| Total Liabilities And Equity | $213,333 | $230,528 | $222,059 | $226,585 | $244,220 |